In a prospective MRI study the presence, appearance, volume, and regional cerebral blood flow (rCBF) correlates of periventricular hyperintensities (PVHs) and deep white matter hyperintensities (DWMHs) were examined in 18 patients with probable Alzheimer's disease and in 10 age matched healthy control subjects, all without major cerebrovascular risk factors. The 133Xe inhalation method and the [9"-Tc]-d,l-hexamethyl-propyleneamine-oxime (HMPAO) technique with single photon emission computed tomography (SPECT) were used to measure rCBF. Rating scores for PVHs were significantly higher in the Alzheimer's disease group (p < 0.01) and correlated significantly with the volume ofventricles (p < 0.05) and with systolic arterial blood pressure (p < 0.01), but not with rCBF.
Abstract
In a prospective MRI study the presence, appearance, volume, and regional cerebral blood flow (rCBF) correlates of periventricular hyperintensities (PVHs) and deep white matter hyperintensities (DWMHs) were examined in 18 patients with probable Alzheimer's disease and in 10 age matched healthy control subjects, all without major cerebrovascular risk factors. The 133Xe inhalation method and the [9" -Tc]-d,l-hexamethyl-propyleneamine-oxime (HMPAO) technique with single photon emission computed tomography (SPECT) were used to measure rCBF. Rating scores for PVHs were significantly higher in the Alzheimer's disease group (p < 0.01) and correlated significantly with the volume ofventricles (p < 0.05) and with systolic arterial blood pressure (p < 0.01), but not with rCBF.
By contrast, there was no significant difference in the rating scores or volumes of DWMHs between the two groups, although three patients had extensive DWMH lesions in the central white matter. In the group of patients with Alzheimer's disease as a whole, the volume of DWMHs correlated well with rCBF in the hippocampal region (r = -0-72; p < 0'001), but not histologically (fig 2) .
Some of the lesions were easily identified as small areas of demyelination infiltrated with macrophages and with astrocytosis. In other lesions, the only obvious change was astrocytosis identified by increased immunoreactivity in glial fibrillary acid protein immunohistostains. In some of these lesions a slight pallor in the myelin stain suggested oedematous dispersion of fibre tracts, but obvious demyelination was not present. In all lesions hyalinised blood vessels were present, but complete obstruction or thrombosis was not found.
Discussion
The highly significant correlation between the volume of DWMHs and hypoperfusion in the hippocampal regions suggested that DWMHs may be a marker for the severity of dysfunction or atrophy in medial temporal lobe structures. This study also showed that white matter hyperintensities could not explain the characteristic topographical heterogeneity of focal cortical rCBF deficits in dementia of the Alzheimer type. Therefore, the heterogeneity must reflect variations in the topography of cortical pathology. We used an MRI scoring method that distinguished between PVHs and DWMHs, because histological and epidemiological studies have suggested a different aetiology for these categories of white matter lesions."3 23 24 The inter-rater reliability of the scoring method has been shown to be very high,5 and in our study the qualitative estimation of DWMHs was refined by quantitative volumetric measurements. The PVH foci just anterior to the frontal horns probably do not reflect pathology. They are thought to be caused by an age related loss of ependyma leading to increased water content. 23 Thus if a PVH score greater than 1 is abnormal, then abnormal PVHs (continuous PVHs along the side of the ventricles) were seen in 50% of our patients with Alzheimer's disease but not in any of the healthy subjects. The PVH scores correlated significantly with systolic arterial blood pressure, but differences in blood pressure could not explain the differences in PVHs between the two groups. The low frequency of PVHs in our group of healthy subjects without major cerebrovascular risk factors corresponds to that reported by Fazekas et al. 25 The increased frequency and extension of PVHs in patients with Alzheimer's disease, which suggested that PVHs may be associated with the Alzheimer's disease process, is in agreement with the findings of McDonald et al. 26 By contrast, Leys et al, 6 Kozachuk et al,5 and Fazekas et al27 failed to find any difference in PVHs between patients with Alzheimer's disease and healthy subjects. Scheltens et al7 found increased severity of PVHs in his group of patients with Alzheimer's disease and with senile onset of disease, but not in presenile onset Alzheimer's disease. We were unable to show any association between the severity of PVHs and age of onset or duration of symptoms. Thus whereas our data on the presence of PVHs in Alzheimer's disease confirmed the results of some, but not all, previous reports, the important finding was that although PVHs were significantly associated with the diagnosis of Alzheimer's disease PVHs were not a determining factor for the cortical rCBF deficits or for global cognitive performance.
By contrast with PVHs the rating scores and volumes of DWMHs were not higher in the group of patients with Alzheimer's disease as a whole. Solitary foci of DWMHs were seen in 70% of our control subjects, a high frequency that corresponds with that reported by Fazekas et al." The lack of difference in DWMH scores between patients with Alzheimer's disease and normal subjects was in agreement with the findings of some previous reports,'s628 but contradicted others.' [29] [30] [31] [32] [33] It is well known that the presence of cerebrovascular risk factors increases the risk of DWMHs,26 '6 and Scheltens et The literature on histopathological examination of MRI white matter lesions in Alzheimer's disease is sparse: in a preliminary postmortem report on three patients with definite Alzheimer's disease Morris et al36 found increased water content, but no histological lesions, in regions with "periventricular high signals". Whether these high signals represented deep white matter hyperintensities or periventricular hyperintensities was not defined in their report, and the vessels were not described. We were able to perform a postmortem neuropathological examination of the brain from one of our patients with definite Alzheimer's disease and extensive DWMH lesions on MRI. The partial loss of myelin and astrocytic gliosis, which was seen in the white matter regions corresponding to those containing DWMHs on MRI, resembled some of the abnormalities described in the necropsy studies by Brun and Englund in patients with Alzheimer's disease.' Similar histopathological changes were found, however, by Fazekas et al24 in healthy subjects with DWMHs on MRI. In our patient hyalinised blood vessels were found in the central white matter, but they were not associated with vessel occlusion or ischaemic changes. Thus perivascular damage could not be proved to be the substrate of the DWMHs. We suggest that neither the DWMHs on MRI nor the histological white matter findings in our patient were related to the Alzheimer's disease process. Most likely DWMHs seen on MRI are related to normal aging, cerebrovascular risk factors, and chronic cerebrovascular disease,37 rather than to the Alzheimer's disease process. The prevalent histological white matter disorder described by Brun and Englund' in Alzheimer's disease as well as our finding of a significant correlation between the volume of DWMHs and hypoperfusion in the hippocampal regions, however, support the hypothesis of a pathophysiological link between DWMHs and Alzheimer's disease.
The DWMHs did not contribute to the characteristic cortical rCBF deficits in Alzheimer's disease. The finding was confirmed with the '33Xe inhalation method as well as with the [99mTc]-d,l-HMPAO technique for measuring rCBF. In accordance with this, measurements of glucose metabolism with PET have failed to show hypometabolism of cortical areas adjacent to white matter hyperintensities.? Although none of our patients had chronic arterial hypertension, the significant correlation between the severity of PVHs (and to some extent also DWMHs) and systolic arterial blood pressure supports the hypothesis that arterial blood pressure may be an aetiological factor for white matter hyperintensities.
In conclusion, clinically diagnosed Alzheimer's disease without major cerebrovascular risk factors was associated with an increased frequency and severity of PVHs. There was no relation, however, between the presence of PVHs and global cognitive performance or the.rCBF patterns. By contrast, DWMHs were not significantly associated with the diagnosis of Alzheimer's disease. The histopathology of extensive DWMH lesions in one patient with Alzheimer's disease included partial loss of myelin and astrocytosis, changes that were not different from those described in normal subjects with DWMHs.
Within the group of patients with Alzheimer's disease, however, the variation in DWMH volumes was high, and the total volume of DWMHs correlated significantly with the reduction of rCBF in the hippocampal regions, suggesting a pathophysiological link between DWMHs and Alzheimer's disease. The characteristic and heterogeneous topography of focal cortical rCBF deficits in probable Alzheimer's disease could not be explained by deafferentation from white matter hyperintensities and therefore must reflect variations in the topography of cortical abnormalities.
NEUROLOGICAL STAMP Dorothea Lynde Dix (1802-87) Dorothea Dix came from New England. Here she noticed the horrible conditions in an asylum. Some warders made a small charge for visitors to come and look at the mad and prod them into raving antics. In 1841 she laid before the Massachusetts General Assembly a description of the insane in jails and private institutions. She spent the rest of her life fighting to improve conditions of the insane.
Anton Ashley Cooper, afterwards Lord Shaftesbury, had discovered similar problems in England 10 years earlier while sitting on a Royal Commission to investigate such conditions. The lunatics at Bedlam were long regarded as one of the sights of London.
Miss Dix travelled thousands of miles by stagecoach, steamboat, and on horseback and quietly collected facts, which she recorded in sober restrained prose. She possessed great charm and a commanding voice. With these attributes, facts collected from a comprehensive study of asylums, and a selection of public speakers to sustain protest she harassed officials and influenced legislatures.
In 1843, in the face of her continuing investigation and increasing community agitation, the Massachusetts Legislature passed a Bill providing for adequate hospitalisation of the insane. This was her first triumph. She became an effective lobbyist in many of the States and a national figure. Her work and influence also led to improvement of the conditions of the insane in Great Britain-and also in Italy after an audience with the Pope. She travelled in Europe and crusaded for human rights of patients until her death at the age of 85.
The centennial of her death, 1987, went largely unnoticed but in 1980 a United States postage stamp had commemorated the first woman who brought the plight of the mentally ill into such prominence (Stanley Gibbons 18188, Scott 1844).
L F HAAS

